Hematologic Malignancy
Juvenile Xanthogranuloma
CI-CAN-00001049JXGExplore in graph →
HematologicNon-malignant2 active trials
Loading cancer entity…
Hematologic Malignancy
CI-CAN-00001049JXGExplore in graph →
Clinical trials
2 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT04079179 | Cobimetinib in Refractory Langerhans Cell Histiocytosis (LCH), and Other Histiocytic Disorders(NACHO-COBI) | recruiting | Phase 2 | 90 | Carl AllenOTHER | 1 | Sep 18, 2025 | clinicaltrials |
Data updated 22 days agoSource updated Sep 18, 2025source: clinicaltrials